Overview

Open-label Extension to Protocol 1042-0600

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
To allow open-label extension to patients who have completed Protocol 1042-0600.
Phase:
Phase 2
Details
Lead Sponsor:
Marinus Pharmaceuticals
Treatments:
Ganaxolone
Pregnanolone